Handle region peptide,rat
DOTA derivative
Sotirimod(R850)
ADPS(ESPAS)
ALPS(N-Ethyl-N-sulfopropylaniline sodium salt)
CNP-AFU(2-Chloro-4-nitrophenylα-L-fucopyranoside)
Thymus peptide C
Setmelanotide(RM-493)
thio-Miltefosine
Resolvin D3
oxy-Arachidonoyl Ethanolamide
Neuromedin U-25(human)
MC 70
Kinsenoside
Kibdelone B
C16((±)-2'-hydroxy)dihydro Ceramide(d18:0/16:0)
1',4"-Sophorolactone 6',6"-diacetate
(2R)-Glycerol-O-β-D-galactopyranoside
Nerolidol
Leukotriene A3 methyl ester
8-iso-15-keto Prostaglandin E2
8-iso-13,14-dihydro-15-keto Prostaglandin F2α
9(S)-HODE-d4 MaxSpec? Standard
CP 20961
NS 6180
ML 349
NKY 80
GT 2016
SB 202474
KN-92 hydrochloride
CYM 50308
BMS 493
SN 003
Oncrasin 1
RWJ 50271
A 412997 dihydrochloride
Cidofovir dihydrate
PMPA(NAALADase inhibitor)
Zolantidine dimaleate
Desmethyl-YM 298198
STF 083010
Tetracaine HCl
Zaprinast
SR3335
Bilobalide
Eltrombopag
Glibenclamide
ML-090
ZM 306416
[D-Trp7,9,10]-Substance P
BAY 61-3606 dihydrochloride
SCR7
HAT Inhibitor II
Ethynodiol diacetate
VU 0360223
Dioctanoylglycol
OctMAB
(Z-Ala-Ala-Ala-Ala)2Rh110
Argatroban
L-R4W2